G. Walker

发表

Post-radiotherapy prostate biopsies reveal heightened apex positivity relative to other prostate regions sampled.

R. Stoyanova, E. Horwitz, N. Dogan, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Volumetric spectroscopic imaging of glioblastoma multiforme radiation treatment volumes.

A. Markoe, R. Stoyanova, A. Maudsley, 2014, International journal of radiation oncology, biology, physics.

Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.

H. Federoff, H. Nechushtan, W. Bowers, 2007, Cancer research.

A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere

H. Soares, Mark R. Green, G. Lopes, 2014, Cancer Chemotherapy and Pharmacology.

Neoadjuvant Treatment for Resectable Cancer of the Esophagus and the Gastroesophageal Junction: A Meta-Analysis of Randomized Clinical Trials

A. Livingstone, G. Walker, D. Franceschi, 2003, Annals of Surgical Oncology.

Phase-2 Study of R-MACLO-IVAM-T in Newly Diagnosed Mantle Cell Lymphoma.

I. Lossos, D. Morgensztern, G. Walker, 2007 .

Five Year Results of a Randomized External Beam Radiotherapy Hypofractionation Trial for Prostate Cancer

R. Stoyanova, E. Horwitz, S. Feigenberg, 2011 .

FOXP3 Subcellular Localization Predicts Recurrence in Oral Squamous Cell Carcinoma

C. Gomez-Fernandez, R. Nazarian, G. Walker, 2013, PloS one.

Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

R. Stoyanova, E. Horwitz, R. Uzzo, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lack of survival improvement in patients with peripheral T-cell lymphoma: a Surveillance, Epidemiology, and End Results analysis

I. Lossos, L. Koniaris, D. Morgensztern, 2011, Leukemia & lymphoma.

CD8 T cell response in a phase I study of therapeutic vaccination of advanced NSCLC with allogeneic tumor cells secreting endoplasmic reticulum-chaperone gp96-Ig-peptide complexes *

L. Raez, E. Podack, G. Walker, 2013 .

Spinal cord gliomas: A multi-institutional retrospective analysis.

A. Markoe, B. Scheithauer, E. Shaw, 2006, International journal of radiation oncology, biology, physics.

Immunohistochemical Expression of Estrogen Receptor in Adenocarcinomas of the Lung: The Antibody Factor

C. Gomez-Fernandez, M. Nadji, G. Walker, 2010, Applied immunohistochemistry & molecular morphology : AIMM.

Oncogenic IRFs Provide a Survival Advantage for Epstein-Barr Virus- or Human T-Cell Leukemia Virus Type 1-Transformed Cells through Induction of BIC Expression

G. Barber, G. Walker, Ling Wang, 2011, Journal of Virology.

Efficacy and Toxicity of Chemoradiotherapy with Carboplatin and Irinotecan Followed by Consolidation Docetaxel for Unresectable Stage III Non-small Cell Lung Cancer

L. Raez, G. Lopes, G. Walker, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question

L. Koniaris, K. Arheart, A. Livingstone, 2006, Journal of Gastrointestinal Surgery.

Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer

R. Stoyanova, E. Horwitz, A. Pollack, 2017, Journal of the National Cancer Institute.

A Phase I Study using low-dose fractionated whole abdominal radiotherapy as a chemopotentiator to full-dose cisplatin for optimally debulked stage III/IV carcinoma of the endometrium.

Matthew J. Pearson, L. Twiggs, K. Saigal, 2011, Gynecologic oncology.

A Novel Applicator for Intracavitary Low-Dose-Rate Brachytherapy (LDR) for Carcinoma of the Uterine Cervix: Results of a Single Institutional Trial

Xiaodong Wu, C. Takita, A. Wolfson, 2010 .

P63 differentiates subtypes of nonsmall cell carcinomas of lung in cytologic samples

C. Gomez-Fernandez, M. Jordá, G. Walker, 2009, Cancer.

High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89-C-41 regimen, in patients with newly diagnos

I. Lossos, D. Morgensztern, P. Hosein, 2010, Leukemia & lymphoma.

Family history of cancer, oral contraceptive use, and ovarian cancer risk.

J. Schlesselman, R. Ness, G. Walker, 2002, American journal of obstetrics and gynecology.

High Remission Rates and Prolonged Progression Free Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma Treated with R-MACLOIVAM-T

I. Lossos, D. Morgensztern, P. Hosein, 2008 .

Neoadjuvant, surgery and adjuvant chemotherapy without radiation for esophageal cancer.

A. Livingstone, G. Walker, P. Ganjei‐Azar, 2007, Japanese journal of clinical oncology.

Neoadjuvant and adjuvant chemotherapy without radiation for esophageal cancer.

A. Livingstone, G. Walker, P. Ganjei‐Azar, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Usefulness of arterial compliance in the thigh in predicting exercise capacity in individuals without coronary heart disease.

L. Mosca, S. Homma, D. Herrington, 2005, The American journal of cardiology.

Phase II trial of capecitabine and docetaxel as second line therapy for locally advanced and metastatic pancreatic cancer

E. Roman, G. Lopes, M. Green, 2007 .

I. Lossos, D. Morgensztern, P. Hosein, 2010, Leukemia & lymphoma.

Gemcitabine and oxaliplatin (GEMOX), a promissing combination for the treatment of relapsed, advanced or metastatic non small cell lung cancer (NSCLC)

C. Calfa, L. Raez, G. Lopes, 2008 .

Gemcitabine in combination with oxaliplatin as second-line therapy of advanced and metastatic NSCLC

A. Alencar, L. Raez, G. Lopes, 2007 .